Suppr超能文献

[进展期胃癌脾门淋巴结转移及清扫技术分析]

[Analysis of splenic hilar lymph node metastasis in advanced gastric cancer and dissection techniques].

作者信息

Zhang Cheng-hai, Wu Ai-wen, Li Zi-yu, Zhang Lian-hai, Bu Zhao-de, Wu Xiao-jiang, Zong Xiang-long, Li Shuang-xi, Shan Fei, Ji Jia-Fu

机构信息

Department of Gastrointestinal Surgery, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, China.

出版信息

Zhonghua Wei Chang Wai Ke Za Zhi. 2011 Aug;14(8):589-92.

Abstract

OBJECTIVE

To study the status of splenic hilar lymph nodes(No.4sa, No.10 or No.11d lymph nodes) metastasis and to investigate the proper dissection technique in patients with advanced gastric cancer.

METHODS

A retrospective study was performed to investigate 590 patients who underwent D2 curative proximal or total gastrectomy for gastric carcinoma from January 2006 to December 2009. Clinicopathological factors such as sex, age, location of the primary tumor, tumor sizes, gross type, depth of invasion, microscopic classification, neoadjuvant chemotherapy and the metastasis of adjacent lymph node were analyzed with univariate and multivariate analysis. Influence of combined splenectomy or pancreatectomy on lymph node dissection was also investigated.

RESULTS

The overall ratio of metastatic lymph node(positive lymph nodes/lymph nodes harvested) in the splenic hilum was 17.5%(99/565). The positive rates of No.4sa, No.10, No.11d lymph nodes were 17.8% (41/230), 13.9%(29/209), and 22.8%(29/127), respectively. A total of 7.1%(42/590) of the patients had lymph node metastasis in the splenic hilum. Multivariable logistic regression analysis showed that age, tumor size, depth of tumor invasion, positive metastasis of No.4sb lymph node were independent risk factors for lymph node metastasis in the splenic hilum region. When comparing patients undergoing combined splenectomy or pancreatectomy(n=23) and those who did not undergo combined organ resection (n=553), the ratios of metastatic lymph node in the splenic hilum were 14.8%(4/27) and 17.2%(91/527), respectively, and the difference was not statistically significant(P>0.05). The postoperative complication rates were 26.1%(6/23) and 5.4%(30/553), respectively, and the difference was statistically significant(P<0.05). The operative mortality rates were 4.3% and 0.9%, respectively, and the difference was not statistically significant(P>0.05).

CONCLUSIONS

Metastasis to lymph nodes in the splenic hilum region in patients with gastric cancer possesses a certain pattern, and it is associated with tumor location, size, depth of invasion, and metastasis in No.4sb. Combined resection of the spleen or pancreas does not result in increased number of harvested lymph nodes or positive lymph nodes, yet is associated with higher complication rate. Therefore, combined organ resection should be meticulous.

摘要

目的

研究脾门淋巴结(第4sa、第10或第11d组淋巴结)转移情况,探讨进展期胃癌患者合适的清扫技术。

方法

进行一项回顾性研究,调查2006年1月至2009年12月期间接受D2根治性近端或全胃切除术治疗胃癌的590例患者。对性别、年龄、原发肿瘤部位、肿瘤大小、大体类型、浸润深度、病理分类、新辅助化疗及相邻淋巴结转移等临床病理因素进行单因素和多因素分析。还研究了联合脾切除术或胰腺切除术对淋巴结清扫的影响。

结果

脾门处转移淋巴结的总体比例(阳性淋巴结数/清扫淋巴结总数)为17.5%(99/565)。第4sa、第10、第11d组淋巴结的阳性率分别为17.8%(41/230)、13.9%(29/209)和22.8%(29/127)。共有7.1%(42/590)的患者脾门处有淋巴结转移。多因素logistic回归分析显示,年龄、肿瘤大小、肿瘤浸润深度、第4sb组淋巴结阳性转移是脾门区淋巴结转移的独立危险因素。比较接受联合脾切除术或胰腺切除术的患者(n = 23)和未接受联合脏器切除术的患者(n = 553),脾门处转移淋巴结的比例分别为14.8%(4/27)和17.2%(91/527),差异无统计学意义(P > 0.05)。术后并发症发生率分别为26.1%(6/23)和5.4%(30/553),差异有统计学意义(P < 0.05)。手术死亡率分别为4.3%和0.9%,差异无统计学意义(P > 0.05)。

结论

胃癌患者脾门区淋巴结转移具有一定规律,与肿瘤位置、大小、浸润深度及第4sb组淋巴结转移有关。联合脾切除术或胰腺切除术不会增加清扫淋巴结数或阳性淋巴结数,但并发症发生率较高。因此,联合脏器切除术应谨慎进行。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验